Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference

(ASX – Trade24:ATH.AX),(NASDAQ:ATHE), MELBOURNE, Australia and SAN FRANCISCO, Nov. 12, 2025 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer of Alterity, will deliver a corporate update at the Bell […]

Fluor Corporation (FLR) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of November 14, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / November 12, 2025 / If you suffered a loss on your Fluor Corporation (NYSE:FLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fluor-corporation-lawsuit-submission-form?prid=176905&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference

Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference GlobeNewswire November 12, 2025 MELBOURNE, Australia and SAN FRANCISCO, Nov. 12, 2025 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief

1911 Gold Announces C$20 Million “Best Efforts” Life Offering and Private Placement

(TSX-V:AUMB),(OTC US:AUMBF),(Other OTC:AUMBF),(Boerse Frankfurt – Freiverkehr:2KY), / NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / VANCOUVER, British Columbia, Nov. 12, 2025 (GLOBE NEWSWIRE) — 1911 Gold Corporation (“1911 Gold” or the “Company“) (TSXV: AUMB; FRA: 2KY) is pleased to announce that it has entered into an agreement

COSCO SHIPPING Global Employees’ CIlE Experience

“Themindset of COSCO SHIPPING and the goal of CIIE is the same, to gather all people of each continent together,”said Evdoxia Kastrinelli from Greece. From November 5 to 10, the Eighth China International Import Expo (CIIE) was successfully held in Shanghai. Employees of COSCO SHIPPING from all over the world gathered at the CIIE, participating

Levi & Korsinsky Urges aTyr (ATYR) Shareholders to Act Before Lead Plaintiff Deadline December 8, 2025

NEW YORK, NY / ACCESS Newswire / November 12, 2025 / If you suffered a loss on your aTyr Pharma, Inc. (NASDAQ:ATYR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/atyr-pharma-inc-lawsuit-submission-form?prid=176898&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

1911 Gold Announces C$20 Million “Best Efforts” Life Offering and Private Placement

1911 Gold Announces C$20 Million “Best Efforts” Life Offering and Private Placement GlobeNewswire November 12, 2025 / NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / VANCOUVER, British Columbia, Nov. 12, 2025 (GLOBE NEWSWIRE) — 1911 Gold Corporation (“1911 Gold” or the “Company“) (TSXV: AUMB; FRA: 2KY) is

Ongoing Investigation: Molina Healthcare, Inc. (MOH) May Have Misled Shareholders – Levi & Korsinsky Investigates

NEW YORK, NY / ACCESS Newswire / November 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Molina Healthcare, Inc. ("Molina Healthcare, Inc.") (NYSE:MOH) concerning possible violations of federal securities laws. On October 23, 2025, Molina published its third quarter, fiscal 2025 earnings well below consensus and slashed its

Investors Urged to Contact Levi & Korsinsky for Information Before November 17, 2025 – Cytokinetics, Incorporated (CYTK)

NEW YORK, NY / ACCESS Newswire / November 12, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=176897&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Scroll to Top